Update on Erythropoiesis-Stimulating Agents Administered to Neonates for Neuroprotection.
Document Type
Article
Publication Date
11-1-2019
Abstract
Erythropoiesis-stimulating agents (ESAs) such as erythropoietin and darbepoetin have been studied as red blood cell growth factors in preterm and term infants for more than 30 years. Recently, studies have focused on the potential neuroprotective effects of ESAs. In this review, we summarize preclinical animal models and recent clinical trials that provide evidence for ESAs as potential treatments to improve neurodevelopmental outcomes in preterm and term infants.
Publication Title
Neoreviews
ISSN
1526-9906
Volume
20
Issue
11
First Page
622
Last Page
622
Recommended Citation
Maxwell, Jessie R and Robin K Ohls.
"Update on Erythropoiesis-Stimulating Agents Administered to Neonates for Neuroprotection.."
Neoreviews
